Infinity Pharmaceuticals | INFI - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.61B 207M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Plus Therapeutics USD 10.73M 189K 2023-12
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12